G1 Therapeutics Gross Margin 2016-2024 | GTHX
Current and historical gross margin for G1 Therapeutics (GTHX) over the last 10 years. The current gross profit margin for G1 Therapeutics as of June 30, 2024 is %.
Gross Margin Historical Data |
Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
2024-06-30 |
$0.06B |
$0.05B |
89.66% |
2024-03-31 |
$0.08B |
$0.08B |
92.77% |
2023-12-31 |
$0.08B |
$0.08B |
91.46% |
2023-09-30 |
$0.08B |
$0.07B |
90.91% |
2023-06-30 |
$0.09B |
$0.08B |
93.26% |
2023-03-31 |
$0.06B |
$0.05B |
89.66% |
2022-12-31 |
$0.05B |
$0.05B |
90.38% |
2022-09-30 |
$0.05B |
$0.04B |
89.58% |
2022-06-30 |
$0.03B |
$0.03B |
86.21% |
2022-03-31 |
$0.03B |
$0.02B |
84.00% |
2021-12-31 |
$0.03B |
$0.03B |
90.63% |
2021-09-30 |
$0.04B |
$0.04B |
95.35% |
2021-06-30 |
$0.07B |
$0.06B |
98.46% |
2021-03-31 |
$0.06B |
$0.06B |
100.00% |